Two Sigma Investments, LP Aprea Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	SELL	$0.71 - $13.6 $30,913 - $592,144	-43,540 Reduced 72.11%	16,843 $11,000
Q2 2022 Aug 15, 2022	BUY	$0.62 - $1.94 $25,899 - $81,039	41,773 Added 224.47%	60,383 $45,000
Q1 2022 May 16, 2022	BUY	$1.59 - $3.16 $29,589 - $58,807	18,610 New	18,610 $35,000
Q2 2021 Aug 16, 2021	SELL	$4.05 - $5.5 $1.31 Million - $1.78 Million	-323,362 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.73 - $8.15 $778,312 - $1.34 Million	164,548 Added 103.61%	323,362 $1.65 Million
Q4 2020 Feb 16, 2021	BUY	$4.92 - $30.67 $781,364 - $4.87 Million	158,814 New	158,814 $781,000

Others Institutions Holding APRE

# of Institutions

2

Shares Held

899

Call Options Held

0

Put Options Held

0

Nbc Securities, Inc. Birmingham, AL

899
Shares

$2,589
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Aprea Therapeutics, Inc.

Ticker APRE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Description
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...

More about APRE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.